Ivan Vrhovec
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Cell Adhesion Molecules Research 12
-
- Protease and Inhibitor Mechanisms 24
- Co-authors
- J ŠkrkJanko KosMarta KrašovecPrimož StrojanMarjan BudihnaLojze ŠmidBranka SveticSimona Borštnar
- Journals
- The International Journal of Biological Markers (6 papers)Anti-Cancer Drugs (2 papers)Clinical Breast Cancer (1 paper)European Journal of Cancer (1 paper)Journal of Neuro-Oncology (1 paper)
- Partner nations
- SloveniaCroatiaUnited States
In The Last Decade
Ivan Vrhovec
34 papers receiving 847 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 523
- Immunology and Allergy 118
- Oncology 302
- Rheumatology 110
- Hematology 79
Countries citing papers authored by Ivan Vrhovec
This map shows the geographic impact of Ivan Vrhovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Vrhovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Vrhovec more than expected).
Fields of papers citing papers by Ivan Vrhovec
This network shows the impact of papers produced by Ivan Vrhovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Vrhovec. The network helps show where Ivan Vrhovec may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Vrhovec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma. | 2003 | 16 |
| 2 | 2002 | 25 | |
| 3 | 2002 | 6 | |
| 4 | 2002 | 47 | |
| 5 | Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck. | 2001 | 17 |
| 6 | 2000 | 19 | |
| 7 | 2000 | 5 | |
| 8 | 1999 | 14 | |
| 9 | 1998 | 37 | |
| 10 | 1998 | 21 | |
| 11 | 1998 | 10 | |
| 12 | 1997 | 9 | |
| 13 | 1997 | 19 | |
| 14 | Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. | 1997 | 153 |
| 15 | 1997 | 46 | |
| 16 | 1996 | 69 | |
| 17 | 1995 | 3 | |
| 18 | 1995 | 86 | |
| 19 | 1990 | 8 | |
| 20 | Treatment of ectopic pregnancy with prostaglandin E2. | 1989 | 6 |
About Ivan Vrhovec
Ivan Vrhovec is a scholar working on Immunology and Allergy, Cancer Research, Genetics, Oncology and Hematology, having authored 34 papers that have together received 871 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (24 papers), Cell Adhesion Molecules Research (12 papers), Bone health and treatments (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Peptidase Inhibition and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Bone and Dental Protein Studies (3 papers) and Bone Metabolism and Diseases (3 papers). The work is most often cited by research in Cancer Research (523 citations), Immunology and Allergy (118 citations), Oncology (302 citations), Rheumatology (110 citations) and Hematology (79 citations). Ivan Vrhovec has collaborated with scholars based in Slovenia, Croatia and United States. Frequent co-authors include J Škrk, Janko Kos, Marta Krašovec, Primož Strojan, Marjan Budihna, Lojze Šmid, Branka Svetic, Simona Borštnar, Borut Štabuc and Nataša Kopitar‐Jerala. Their work appears in journals such as The International Journal of Biological Markers, Anti-Cancer Drugs, Clinical Breast Cancer, European Journal of Cancer and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.